Human IFN gamma ELISpot Set

Contact us
Diaclone
Product Code: 856.051.001
Product Group: ELISpot Kits
Supplier: Diaclone
CodeSizePrice
856.051.0011 x 96 Discovery (plate not included)£197.00
Quantity:
Prices exclude any Taxes / VAT

Overview

Host Type: Human
Regulatory Status: RUO
Application: ELISpot

Further Information

Additional 2:
Spots read visually or with reader
Antigen Synonyms:
IFN-g IFN-gamma
Cross reaction:
No cross reactivity with other human cytokines. Cross reactivity with simian IFN-g.
Description:
Diaclone ELISpot Sets include capture and detection antibodies Streptavidin - Alkaline Phosphatase conjugated BSA BCIP/NTB blocking reagent.
Detection Target:
IFN gamma
Incubation:
3h after cell stimulation
Reactivity:
Human
Research Area:
Cytokines / Growth Factors
Specificity:
Recognizes natural human IFN-g

References

  1. Adotevi O. et al. Clin Cancer Res.2006; 12(10): 3158-67.. Immunogenic HLA-B*0702-restricted epitopes derived from human telomerase reverse transcriptase that elicit antitumor cytotoxic T-cell responses. https://www.ncbi.nlm.nih.gov/pubmed/16707616
  2. Alatrakchi N. et al. AIDS 2002; 16(5): 713 - 717. Strong CD4 Th1 responses to HIV and hepatitis C virus in HIV-infected long-term non-progressors co-infected with hepatitis C virus. https://www.ncbi.nlm.nih.gov/pubmed/14500478
  3. Almeida J. R. et al.Blood2009; 113(25): 6351-6360.. Antigen sensitivity is a major determinant of CD8+ T-cell polyfunctionality and HIV-suppressive activity. https://www.ncbi.nlm.nih.gov/pubmed/19389882
  4. Almeida J. R. et al. J. Exp. Med.2007; 204(10): 2473-2485.. Superior control of HIV-1 replication by CD8+ T cells is reflected by their avidity polyfunctionality and clonal turnover. https://www.ncbi.nlm.nih.gov/pubmed/17893201
  5. Anguille S. et al.PLoS One2012; 7(12): e51851. Interleukin-15-induced CD56(+) myeloid dendritic cells combine potent tumor antigen presentation with direct tumoricidal potential.. https://www.ncbi.nlm.nih.gov/pubmed/23284789
  6. Ascough S. et al. J Infect.2014?;68(2): 200-3. Injectional anthrax infection due to heroin use induces strong immunological memory.. https://www.ncbi.nlm.nih.gov/pubmed/24513100
  7. Ascough S.J. et al.PLoS Pathog.2014; 10(5): e1004085. Anthrax lethal factor as an immune target in humans and transgenic mice and the impact of HLA polymorphism on CD4+ T cell immunity.. https://www.ncbi.nlm.nih.gov/pubmed/24788397
  8. Ayyoub M. et al. J. Immunol. 2002; 168(4):1717 - 1722. Proteasome-assisted identification of a SSX-2-derived epitope recognized by tumor-reactive CTL infiltrating metastatic melanoma. https://www.ncbi.nlm.nih.gov/pubmed/11823502
  9. Ayyoub M. et al. J. Immunol. 2004; 172(11): 7206 - 7211. Identification of an SSX-2 Epitope Presented by Dendritic Cells to Circulating Autologous CD4+ T Cells. https://www.ncbi.nlm.nih.gov/pubmed/15153546
  10. Bain C. et al. J. Virol. 2004; 78(19):10460 - 10469. Memory T-Cell-Mediated Immune Responses Specific to an Alternative Core Protein in Hepatitis C Virus Infection. https://www.ncbi.nlm.nih.gov/pubmed/15367612
  11. Barragu? H. et al.Medicine (Baltimore). 2017 Sep;96(39):e7915. Chronic hepatitis E virus infection in a cirrhotic patient: A case report.. https://www.ncbi.nlm.nih.gov/pubmed/28953614
  12. Best I. et al. Immunology2009;128(1 Suppl):e777-86. IFN-gamma production in response to Tax 161-233 and frequency of CD4+ Foxp3+ and Lin HLA-DRhigh CD123+ cells discriminate HAM/TSP patients from asymptomatic HTLV-1-carriers in a Peruvian population.. https://www.ncbi.nlm.nih.gov/pubmed/19740339
  13. Beziaud L. et al. Cancer Res.2016?; 76(14): 4100-4112. Rapalogs Efficacy Relies on the Modulation of Antitumor T-cell Immunity. https://www.ncbi.nlm.nih.gov/pubmed/27197194
  14. Bolonaki I. et al. J. Clin. Oncol.2007; 25(19): 2727-2734.. Vaccination of Patients With Advanced Non-Small-Cell Lung Cancer With an Optimized Cryptic Human Telomerase Reverse Transcriptase Peptide. https://www.ncbi.nlm.nih.gov/pubmed/17602077
  15. Boustani J. et al. BMC Immunol. 2021; 22: 38. . Cisplatin-based chemoradiation decreases telomerase-specific CD4 TH1 response but increases immune suppressive cells in peripheral blood. https://pubmed.ncbi.nlm.nih.gov/34144673/